...
首页> 外文期刊>European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery >Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study.
【24h】

Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study.

机译:球囊血管成形术治疗肾动脉纤维肌增生异常:一项前瞻性随访研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: to assess restenosis rates and blood pressure response after percutaneous transluminal renal angioplasty (PTRA) in patients treated for fibromuscular dysplastic renal artery stenosis. METHODS: a prospective 12-month follow-up study of 27 patients with 31 treated renal artery stenosis. Follow-up assessment included colour-coded duplex sonography (CCD) of renal arteries, monitoring of blood pressure, antihypertensive medication, and creatinine measurements before discharge and at 3, 6, and 12 months. Primary end point was defined as a haemodynamically significant restenosis >60% assessed by CCD. RESULTS: there was a cumulative 23% restenosis rate at 12 months. Arterial hypertension was cured or improved in 93% of patients immediately after the intervention and remained cured/improved in 74% of patients at 12 months of follow-up. Renal failure present in five patients before PTRA stabilised or improved in all patients. CONCLUSION: although restenosis rate after PTRA in fibromuscular dysplasia is as high as in non-ostial atherosclerotic lesions, there remains a considerable higher therapeutic effect. Profound pressure response and recurrent arterial hypertension with restenosis support the high probability of a renovascular origin of arterial hypertension in this young and otherwise healthy population compared to patients with atherosclerotic renal artery lesions. Copyright 2002 Harcourt Publishers Limited.
机译:目的:评估经皮腔内肾成形术治疗纤维肌增生性肾动脉狭窄的患者的再狭窄率和血压反应。方法:一项前瞻性12个月的随访研究,对27例经治疗的肾动脉狭窄的27例患者进行了研究。随访评估包括肾脏动脉的彩色双工超声检查(CCD),血压监测,降压药物治疗以及出院前以及第3、6和12个月的肌酐测量。主要终点定义为通过CCD评估的血流动力学显着的再狭窄> 60%。结果:12个月累积再狭窄率23%。干预后立即有93%的患者治愈或改善了动脉高压,并在随访12个月时有74%的患者保持了治愈/改善。在所有患者中,在PTRA稳定或改善之前,五名患者存在肾功能衰竭。结论:尽管PTRA后纤维肌增生异常的再狭窄率与非小动脉粥样硬化病变一样高,但仍具有相当高的治疗效果。与患有动脉粥样硬化性肾动脉病变的患者相比,在这一年轻且其他方面健康的人群中,深刻的压力反应和复发性再狭窄引起的高血压是肾脏血管性高血压高发的原因。版权所有2002 Harcourt Publishers Limited。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号